View Item 

Show simple item record

Response to Maccio et al, - Multifactorial pathogenesis of COVID- 19- related coagulopathy: Can defibrotide have a role in the early phases of coagulation disorders?-

dc.contributor.authorRichardson, Edward
dc.contributor.authorCarlo‐stella, Carmelo
dc.contributor.authorJara, Ruben
dc.contributor.authorVlodavsky, Israel
dc.contributor.authorIacobelli, Massimo
dc.contributor.authorFareed, Jawed
dc.contributor.authorMo, Clifton
dc.contributor.authorO’Gorman, Peter
dc.contributor.authorYanik, Gregory
dc.contributor.authorPalomo, Marta
dc.contributor.authorDiaz‐ricart, Maribel
dc.contributor.authorMoraleda, Jose M.
dc.date.accessioned2020-11-04T15:58:45Z
dc.date.availableWITHHELD_13_MONTHS
dc.date.available2020-11-04T15:58:45Z
dc.date.issued2020-11
dc.identifier.citationRichardson, Edward; Carlo‐stella, Carmelo ; Jara, Ruben; Vlodavsky, Israel; Iacobelli, Massimo; Fareed, Jawed; Mo, Clifton; O’Gorman, Peter; Yanik, Gregory; Palomo, Marta; Diaz‐ricart, Maribel ; Moraleda, Jose M. (2020). "Response to Maccio et al, - Multifactorial pathogenesis of COVID- 19- related coagulopathy: Can defibrotide have a role in the early phases of coagulation disorders?- ." Journal of Thrombosis and Haemostasis 18(11): 3111-3113.
dc.identifier.issn1538-7933
dc.identifier.issn1538-7836
dc.identifier.urihttps://hdl.handle.net/2027.42/163392
dc.publisherWiley Periodicals, Inc.
dc.subject.otherVascular Endothelium
dc.subject.otherthrombosis
dc.subject.otherp38 mitogen- activated protein kinases
dc.subject.otherheparanase
dc.subject.otherdefibrotide
dc.subject.otherCOVID- 19
dc.titleResponse to Maccio et al, - Multifactorial pathogenesis of COVID- 19- related coagulopathy: Can defibrotide have a role in the early phases of coagulation disorders?-
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelInternal Medicine and Specialties
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/163392/2/jth15088_am.pdfen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/163392/1/jth15088.pdfen_US
dc.identifier.doi10.1111/jth.15088
dc.identifier.sourceJournal of Thrombosis and Haemostasis
dc.identifier.citedreferenceMacciò A, Madeddu C, Caocci G, La Nasa G. Multifactorial pathogenesis of COVID- 19- related coagulopathy. Can defibrotide have a role in the early phases of coagulation disorders? J Thromb Haemost. 2020;18(11):3106- 3107.
dc.identifier.citedreferenceBuijsers B, Yanginlar C, Grondman I, et al. Increased plasma heparanase activity in COVID- 19 patients. MedRxiv. 2020. https://doi.org/10.1101/2020.06.12.2012930
dc.identifier.citedreferenceGarcía- Bernal D, Palomo M, Martínez CM, et al. Defibrotide inhibits donor leukocyte endothelial interactions and protects against acute graft- versus- host disease. J Cell Mol Med. 2020. First published: 10 June 2020. https://doi.org/10.1111/jcmm.15434
dc.identifier.citedreferenceAckermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endotheliitis, thrombosis, and angiogenesis in Covid- 19. N Engl J Med. 2020; 383: 120 - 128.
dc.identifier.citedreferencePalomo M, Mir E, Rovira M, Escolar G, Carreras E, Diaz- Ricart M. What is going on between defibrotide and endothelial cells? Snapshots reveal the hot spots of their romance. Blood. 2016; 127 ( 13 ): 1719 - 1727.
dc.identifier.citedreferenceGrimes JM, Grimes KV. p38 MAPK inhibition: a promising therapeutic approach for COVID- 19. J Mol Cel Cardiol. 2020; 144: 63 - 65.
dc.identifier.citedreferenceMarchant D, Singhera GK, Utokaparch S, et al. Toll- like receptor 4- mediated activation of p38 mitogen- activated protein kinase is a determinant of respiratory virus entry and tropism. J Virol. 2010; 84 ( 21 ): 11359 - 11373.
dc.identifier.citedreferenceGheblawi M, Wang K, Viveiros A, et al. Angiotensin- converting enzyme 2: SARS- CoV- 2 receptor and regulator of the renin- angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circulation Res. 2020; 126 ( 10 ): 1456 - 1474.
dc.identifier.citedreferenceVarga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID- 19. Lancet. 2020; 395 ( 10234 ): 1417 - 1418.
dc.identifier.citedreferenceRichardson PG, Aggarwal S, Topaloglu O, et al. Systematic review of defibrotide studies in the treatment of veno- occlusive disease/sinusoidal obstruction syndrome (VOD/SOS). Bone Marrow Transplant. 2019; 54: 1951 - 1962.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
jth15088.pdf
Size:
271.7KB
Format:
PDF
View/Open
Name:
jth15088_am.pdf
Size:
159.0KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.